FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to derivatives of glutarimides of general formula (I) 
and their pharmaceutically acceptable salts, medication and pharmaceutical composition on their basis, their application and method of treating diseases of upper respiratory ways, as well as to method of obtaining formula (I) derivatives of glutarimides. In general formula (I) m stands for integer from 0 to 2; Ra 1 and Rc 1 stand for hydrogen, C1-C6alkyl, -NH2 or hydroxygroup; Rb 1, Rd 1 and Re 1 stand for hydrogen or C1-C6alkyl; Rf 1 stands for hydrogen; R2 stands for hydrogen, C1-C6alkyl, group -C(O)OH or -C(O)OC1-C6 alkyl; R3 stands for: 5-membered saturated or unsaturated heterocyclic group, containing from 1 to 4 heteroatoms, selected from N, O and S, optionally substituted with from 1 to 3 substituents, selected from halogen, C1-C6alkyl, C1-C6alkoxy, group -C(O)OH and phenyl; 6-membered saturated or unsaturated heterocyclic group, containing 1 or 2 heteroatoms, selected from N and O, optionally substituted with halogen; 5-membered unsaturated heterocyclic group, containing 1 heteroatom, selected from N and S, optionally substituted with 1 or 2 substituents, selected from C1-C6alkyl, condensed with phenyl or 6-membered unsaturated heterocyclic group, containing nitrogen atom, optionally substituted with one substituent, selected from hydroxygroup or halogen; 6-membered unsaturated cyclic or heterocyclic group, containing 2 N atoms, condensed with 5- or 6-membered unsaturated heterocyclic group, containing from 1 to 3 heteroatoms, selected from N and S; group of formula 
.
EFFECT: obtaining composition for treatment of upper respiratory ways diseases.
25 cl, 5 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLUTARIMIDE DERIVATIVE, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHOD THEREOF | 2015 |
|
RU2610275C2 |
| GLUTARIMIDE DERIVATIVES, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHODS THEREOF | 2015 |
|
RU2610274C2 |
| GLUTARIMIDE DERIVATIVE, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, SYNTHESIS METHODS THEREOF | 2013 |
|
RU2610276C1 |
| ARYL, HETEROARYL AND HETEROCYCLIC COMPOUNDS FOR TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2015 |
|
RU2707749C2 |
| INDOLE DERIVATIVE | 2007 |
|
RU2454415C9 |
| UNSATURATED DERIVATIVES OF HYDROXIMIC ACID AS INHIBITORS OF NAD-ADP-RIBOSYLTRANSFERASE | 1999 |
|
RU2220953C2 |
| 3,4-SUBSTITUTED 1H-PIRAZOLE COMPOUNDS AND THEIR APPLICATION AS CYCLIN-DEPENDANT KINASES (CDK) AND MODULATORS OF GLYCOGEN SYNTHASE KINASE-3 (GSK-3) | 2004 |
|
RU2408585C2 |
| INHIBITIN CDK-KINASES PYRIMIDINES AND THEIR APPLICATION AS MEDICINES | 2002 |
|
RU2330024C2 |
| DICARBOXYLIC ACID BISAMIDE DERIVATIVES, THEIR APPLICATION, THE PHARMACEUTICAL COMPOSITION ON THEIR BASIS, METHODS FOR THEIR PRODUCTION | 2013 |
|
RU2665688C2 |
| SUBSTITUTED ETHERS OF 5-HYDROXY-1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINMENT AND APPLICATION | 2007 |
|
RU2344817C1 |
